Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Signal Twitter WhatsApp

Dollars for Doctors

How Industry Money Reaches Physicians

ProPublica is tracking the financial ties between doctors and medical companies.

Vying for Market Share, Companies Heavily Promote 'Me Too' Drugs

Our comprehensive analysis of drug company spending on doctors in the last five months of 2013 shows the most-promoted products typically were not cures, breakthroughs or top sellers.

Methodology for Calculating Company Payments to Doctors

Even with new federal data, it's not easy to track drug, device company spending on their products

Dollars for Dudes: Almost No Women Among Medical Industry's Top-Paid Speakers, Consultants

The causes are not clear, but men account for more than 90 percent of the 300 doctors who received the most money from drug and medical device companies, according to new federal data.

$1.1 Billion in Drug, Device Payments to Doctors Not Included in New Federal Database

The new Open Payments database of industry payments to doctors and teaching hospitals is more incomplete than previously known.

Analysis: Government's New Doctor Payments Website Worthy of a Recall

Our health reporter Charles Ornstein takes a test drive using the federal government's new website for drug and device payments. He finds it virtually unusable.

Our First Dive Into the New Open Payments System

The government's data on payments to doctors and hospitals by drug and device makers is incomplete and hard to penetrate – but here's a first look.

What to be Wary of in the Govt's New Site Detailing Industry Money to Docs

The government's new website on drug and device company ties to doctors will be incomplete and may be misleading — for now.

What We've Learned From Four Years of Diving Into Dollars for Docs

Payments from pharmaceutical companies touch hundreds of thousands of doctors. The 17 companies we've tracked spent $1.4 billion in 2013 alone. Here are our top five takeaways from following all that money.

More Data to Be Withheld from Database of Physician Payments

The federal government won’t release data next month on some research payments to doctors. Health officials had acknowledged previously that the database wouldn’t include one-third of payments made by pharmaceutical and medical device companies.

Government Will Withhold One-Third of the Records from Database of Physician Payments

Many payments to doctors made by pharmaceutical and medical device companies will not be included in the public release of the database next month. Federal officials cite data inconsistencies, say records will be posted next June.

Top Acthar Prescribers in Medicare Have Ties to Its Maker

The top four prescribers of the drug were promotional speakers, researchers or consultants.

Glitch Prompts Temporary Shutdown of Pharma Payment Verification System

The government had to take offline its system for doctors to verify payments from drug companies after at least one doctor had payments attributed to him that actually went to someone else.

D

Error: You Have No Payments from Pharma

Doctors checking a soon-to-be-unveiled federal website that will publicly list drug company payments are encountering error messages if they have not accepted industry money.

Leaders of Teaching Hospitals Have Close Ties to Drug Companies, Study Shows

Nearly every large drug maker based in the United States had at least one academic medical center official on its board, raising questions about their independence.

Reporting Recipe: Dollars for Docs

With more data on relationships between doctors and drug companies soon to be released, here are some ways journalists can use this information.

Double Dip: Doctors Paid to Advise, Promote Drug Companies That Fund Their Research

Research has been seen as less objectionable than other forms of interactions with drug companies, but 10 percent of researchers have multiple ties among the nine companies ProPublica analyzed. That raises questions about doctors’ impartiality.

Doctor Payments on the Decline

Pharmaceutical company payments to health care professionals dropped between 2011 and 2012 among most of the companies and categories ProPublica tracks, driven in part by increased transparency as well as blockbuster drugs losing patent protection. Research payments, however, have increased among that group.

As Full Disclosure Nears, Doctors’ Pay for Drug Talks Plummets

As transparency increases and blockbuster drugs lose patent protection, drug companies have dramatically scaled back payments to doctors for promotional talks. This fall, all drug and medical device companies will be required to report payments to doctors.

Freed of Disclosure Requirement, Drug Maker Pulls Doctor Payments Offline

Drugmaker Cephalon had been required to post its payments to doctors online as part of a lawsuit settlement. After its agreement expired, it removed them from its website.

Follow ProPublica

Our Latest Stories

Current site Current page